CVS Health (NYSE: CVS) reported Q4 EPS of $1.99, $0.07 better than the analyst estimate of $1.92. Revenue for the quarter came in at $83.85 billion versus the consensus estimate of $76.33 billion.

GUIDANCE:

CVS Health sees FY2023 EPS of $8.70-$8.90, versus the consensus of $8.86.

For earnings history and earnings-related data on CVS Health (CVS) click here.